ANGO Net Margin
-10.12%TTM
Period ending:
ANGO FY Net Margin%
26.69%-72.76%
2001-05-312026-05-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ANGO net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 26 observations from May 31, 2001 to May 31, 2026.
| Period ending | Net Margin |
|---|---|
| -11.4756% | |
| -11.6216% | |
| -60.6583% | |
| -15.4809% | |
| -8.3951% | |
| -10.8409% | |
| -63.1393% | |
| 17.0633% | |
| 4.7446% | |
| -2.0169% | |
| -12.3244% | |
| -0.9491% | |
| 0.6621% | |
| -0.3541% | |
| -2.3369% | |
| 3.7586% | |
| 5.6991% | |
| 5.0919% | |
| 6.5399% | |
| -8.1326% | |
| 8.752% | |
| 7.5437% | |
| 6.4071% | |
| 3.0858% | |
| 3.2664% | |
| 1.4664% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All ANGO financial metrics · ANGO stock overview · How to interpret financial metrics
